These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9928197)

  • 1. Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities.
    Pooga M; Lindgren M; Hällbrink M; Bråkenhielm E; Langel U
    Ann N Y Acad Sci; 1998 Dec; 863():450-3. PubMed ID: 9928197
    [No Abstract]   [Full Text] [Related]  

  • 2. A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain.
    Langel U; Pooga M; Kairane C; Zilmer M; Bartfai T
    Regul Pept; 1996 Apr; 62(1):47-52. PubMed ID: 8738882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galparan: a powerful insulin-releasing chimeric peptide acting at a novel site.
    Ostenson CG; Zaitsev S; Berggren PO; Efendic S; Langel U; Bartfai T
    Endocrinology; 1997 Aug; 138(8):3308-13. PubMed ID: 9231782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and pharmacology of galanin receptors.
    Branchek T; Smith KE; Walker MW
    Ann N Y Acad Sci; 1998 Dec; 863():94-107. PubMed ID: 9928163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.
    Pooga M; Soomets U; Hällbrink M; Valkna A; Saar K; Rezaei K; Kahl U; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
    Nat Biotechnol; 1998 Sep; 16(9):857-61. PubMed ID: 9743120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and gastrointestinal action of galanin.
    Yanaihara N; Mochizuk T; Kuwahara A; Hoshino M; Kakuyama H; Iguchi K; Iwanaga T; Jun L; Futai Y; Kanno T; Yamabe K; Yanaihara C
    Ann N Y Acad Sci; 1998 Dec; 863():129-42. PubMed ID: 9928166
    [No Abstract]   [Full Text] [Related]  

  • 7. Galparan induces in vivo acetylcholine release in the frontal cortex.
    Consolo S; Baldi G; Nannini L; Uboldi MC; Pooga M; Langel U; Bartfai T
    Brain Res; 1997 May; 756(1-2):174-8. PubMed ID: 9187329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-mobilizing actions of chimeric hormone-mastoparan peptides.
    Mezna M; Langel U; Hällbrink M; Wheatley M; Michelangeli F; Howl J
    Biochem Soc Trans; 1997 Aug; 25(3):450S. PubMed ID: 9388674
    [No Abstract]   [Full Text] [Related]  

  • 9. Galanin--a neuropeptide with inhibitory actions.
    Kask K; Langel U; Bartfai T
    Cell Mol Neurobiol; 1995 Dec; 15(6):653-73. PubMed ID: 8719035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
    Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide nucleic acid smugglers.
    Prochiantz A
    Nat Biotechnol; 1998 Sep; 16(9):819-20. PubMed ID: 9743109
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding.
    Kask K; Berthold M; Kahl U; Juréus A; Nordvall G; Langel U; Bartfai T
    Ann N Y Acad Sci; 1998 Dec; 863():78-85. PubMed ID: 9928161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and molecular biology of galanin receptor ligands.
    Langel U; Bartfai T
    Ann N Y Acad Sci; 1998 Dec; 863():86-93. PubMed ID: 9928162
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential regulation of GTPase activity by mastoparan and galparan.
    Zorko M; Pooga M; Saar K; Rezaei K; Langel U
    Arch Biochem Biophys; 1998 Jan; 349(2):321-8. PubMed ID: 9448721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR.
    Lindberg M; Jarvet J; Langel U; Gräslund A
    Biochemistry; 2001 Mar; 40(10):3141-9. PubMed ID: 11258929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological properties of new chimeric galanin analogue GAL(1-13)-[Ala10,11]ET-1(6-21)-NH2.
    Ruczyński J; Konstański Z; Cybal M; Petrusewicz J; Wójcikowski C; Rekowski P; Kamińska B
    J Physiol Pharmacol; 2005 Jun; 56(2):273-85. PubMed ID: 15985708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin receptor subtypes and ligand binding.
    Florén A; Land T; Langel U
    Neuropeptides; 2000 Dec; 34(6):331-7. PubMed ID: 11162289
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell penetration by transportan.
    Pooga M; Hällbrink M; Zorko M; Langel U
    FASEB J; 1998 Jan; 12(1):67-77. PubMed ID: 9438412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide.
    Saar K; Mahlapuu R; Laidmäe E; Valkna A; Kahl U; Karelson E; Langel U
    Regul Pept; 2001 Oct; 102(1):15-9. PubMed ID: 11600206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed.
    Hoyer D
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):14943-4. PubMed ID: 20713719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.